In cancer, HVEM upregulation has been reported in various tumor cell lines and clinical tumor tissue, including breast and esophageal cancer, chronic lymphocytic leukemia, and melanoma [7,13,14,15]. The gene discussed is TNFRSF14; the disease is B-cell chronic lymphocytic leukemia.